Royal Bank Of Canada Amryt Pharma PLC Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.0 - $14.77 $8,855 - $18,684	-1,265 Reduced 42.21%	1,732 $25,000
Q4 2022 Feb 14, 2023	SELL	$6.68 - $7.58 $55,444 - $62,914	-8,300 Reduced 73.47%	2,997 $21,000
Q3 2022 Nov 14, 2022	BUY	$6.8 - $8.01 $76,704 - $90,352	11,280 Added 66352.94%	11,297 $78,000
Q2 2022 Aug 15, 2022	SELL	$6.85 - $8.87 $794 - $1,028	-116 Reduced 87.22%	17 $0
Q4 2021 Feb 14, 2022	SELL	$9.44 - $12.24 $2,303 - $2,986	-244 Reduced 64.72%	133 $1,000
Q3 2021 Nov 15, 2021	BUY	$9.63 - $12.47 $3,197 - $4,140	332 Added 737.78%	377 $4,000
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.29 $490 - $643	45 New	45 $1,000

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.